Food and Drug Administration Scientists Oppose Administration Push to Ease Regulatory Access to Specialized Peptides
Internal documents reveal that senior scientists at the Food and Drug Administration raised formal objections to administration directives aimed at easing regulatory access to certain peptide compounds, highlighting ongoing tension between political appointees and career public health regulators.